Smoking mediates the relationship between SES and brain volume: The CARDIA study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 15 04 2020
accepted: 08 09 2020
entrez: 21 9 2020
pubmed: 22 9 2020
medline: 13 11 2020
Statut: epublish

Résumé

Investigate whether socioeconomic status (SES) was related to brain volume in aging related regions, and if so, determine whether this relationship was mediated by lifestyle factors that are known to associate with risk of dementia in a population-based sample of community dwelling middle-aged adults. We studied 645 (41% black) participants (mean age 55.3±3.5) from the Coronary Artery Risk Development in Young Adults (CARDIA) study who underwent brain magnetic resonance imaging. SES was operationalized as a composite measure of annual income and years of education. Gray matter volume was estimated within the insular cortex, thalamus, cingulate, frontal, inferior parietal, and lateral temporal cortex. These regions are vulnerable to age-related atrophy captured by the Spatial Pattern of Atrophy for Recognition of Brain Aging (SPARE-BA) index. Lifestyle factors of interest included physical activity, cognitive activity (e.g. book/newspaper reading), smoking status, alcohol consumption, and diet. Multivariable linear regressions tested the association between SES and brain volume. Sobel mediation analyses determined if this association was mediated by lifestyle factors. All models were age, sex, and race adjusted. Higher SES was positively associated with brain volume (β = .109 SE = .039; p < .01) and smoking status significantly mediated this relationship (z = 2.57). With respect to brain volume, smoking accounted for 27% of the variance (β = -.179 SE = .065; p < .01) that was previously attributed to SES. Targeting smoking cessation could be an efficacious means to reduce the health disparity of low SES on brain volume and may decrease vulnerability for dementia.

Identifiants

pubmed: 32956388
doi: 10.1371/journal.pone.0239548
pii: PONE-D-20-10895
pmc: PMC7505457
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0239548

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201800003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800006I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800007I
Pays : United States
Organisme : NIA NIH HHS
ID : F31 AG062009
Pays : United States
Organisme : NIH HHS
ID : S10 OD023495
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG063887
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800004I
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist. The affiliation of SS does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

JAMA. 1994 Apr 6;271(13):1004-10
pubmed: 8139057
MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1227-32
pubmed: 19910909
Arch Neurol. 2000 Jan;57(1):85-9
pubmed: 10634453
Ann N Y Acad Sci. 2018 Sep;1428(1):14-32
pubmed: 29947055
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Lancet. 2004 Jan 31;363(9406):392-4
pubmed: 15074306
JAMA. 2010 Mar 24;303(12):1159-66
pubmed: 20332401
PLoS One. 2015 Mar 26;10(3):e0122138
pubmed: 25812012
IEEE Trans Med Imaging. 2002 Nov;21(11):1421-39
pubmed: 12575879
Ann N Y Acad Sci. 2010 Feb;1186:5-23
pubmed: 20201865
Neuron. 2017 Sep 27;96(1):56-71
pubmed: 28957676
Transl Psychiatry. 2016 Apr 05;6:e775
pubmed: 27045845
Am J Epidemiol. 2004 Jan 15;159(2):175-83
pubmed: 14718220
Acad Radiol. 2013 Dec;20(12):1566-76
pubmed: 24200484
JAMA. 2014 Jan 8;311(2):141-3
pubmed: 24399551
Nat Commun. 2016 Jun 21;7:11934
pubmed: 27327500
Psychosom Med. 2017 Jan;79(1):14-23
pubmed: 27428856
PLoS One. 2019 May 9;14(5):e0216338
pubmed: 31071128
Arch Neurol. 1997 Nov;54(11):1399-405
pubmed: 9362989
Neuroimage. 2016 Feb 15;127:186-195
pubmed: 26679328
Drug Alcohol Depend. 2017 Aug 1;177:228-236
pubmed: 28622625
Med Image Comput Comput Assist Interv. 2008;11(Pt 1):620-7
pubmed: 18979798
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Psychosom Med. 2006 Jan-Feb;68(1):41-50
pubmed: 16449410
Arch Intern Med. 2006 Nov 27;166(21):2348-55
pubmed: 17130388
Lancet Neurol. 2011 Sep;10(9):819-28
pubmed: 21775213
Neurology. 1999 Jan 1;52(1):78-84
pubmed: 9921852
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45
pubmed: 24924665
JAMA. 2005 Dec 14;294(22):2879-88
pubmed: 16352796
Alzheimers Dement (Amst). 2016 Apr 09;4:14-7
pubmed: 27489874
JAMA. 1998 Jun 3;279(21):1703-8
pubmed: 9624022
Front Neurosci. 2014 Sep 04;8:276
pubmed: 25249931
Int J Environ Res Public Health. 2015 Jul 16;12(7):8198-213
pubmed: 26193290
Brain. 2016 Apr;139(Pt 4):1164-79
pubmed: 26912649
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Ann N Y Acad Sci. 2012 Feb;1248:107-23
pubmed: 22092035
Neurology. 2002 Sep 24;59(6):887-93
pubmed: 12297572
Am Psychol. 1994 Jan;49(1):15-24
pubmed: 8122813
Transl Psychiatry. 2019 Feb 11;9(1):78
pubmed: 30741945
J Comput Assist Tomogr. 1998 Sep-Oct;22(5):827-37
pubmed: 9754125
J Cardiopulm Rehabil. 1989 Nov;9(11):448-459
pubmed: 29657358
Soc Sci Med. 2011 Mar;72(5):641-9
pubmed: 21316829
Arch Neurol. 2008 Jan;65(1):113-20
pubmed: 18195148
JAMA Intern Med. 2018 Feb 1;178(2):281-282
pubmed: 29255907
J Clin Epidemiol. 1988;41(11):1105-16
pubmed: 3204420
Neuroradiology. 2012 Sep;54(9):929-38
pubmed: 22246242
Am J Epidemiol. 1991 Jun 15;133(12):1231-45
pubmed: 2063831
J Neurol Sci. 2007 Jun 15;257(1-2):177-81
pubmed: 17395207
Neurology. 1999 Apr 22;52(7):1408-12
pubmed: 10227626
Am J Clin Nutr. 2008 May;87(5):1107-17
pubmed: 18469226
Neurology. 2011 Aug 2;77(5):461-8
pubmed: 21810696

Auteurs

Ryan J Dougherty (RJ)

Johns Hopkins University, Baltimore, Maryland, United States of America.
National Institute on Aging, Bethesda, Maryland, United States of America.

Justine Moonen (J)

National Institute on Aging, Bethesda, Maryland, United States of America.

Kristine Yaffe (K)

University of California, San Francisco, San Francisco, California, United States of America.
San Francisco VA Health Care System, San Francisco, California, United States of America.

Stephen Sidney (S)

Kaiser Permanente Division of Research, Oakland, California, United States of America.
Kaiser Permanente of Northern California, Oakland, California, United States of America.

Christos Davatzikos (C)

University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Mohamad Habes (M)

University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Lenore J Launer (LJ)

National Institute on Aging, Bethesda, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH